Skip to main content
PMC home page
Gut logoLink to Gut
. 1997 May;40(5):568–571. doi: 10.1136/gut.40.5.568

Hepatitis B virus infection and liver transplantation.

N A Terrault 1, T L Wright 1
PMCID: PMC1027154  PMID: 9203930

Full text

PDF
568

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus P. W., Locarnini S. A., McCaughan G. W., Jones R. M., McMillan J. S., Bowden D. S. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology. 1995 Jan;21(1):14–18. [PubMed] [Google Scholar]
  2. Benner K. G., Lee R. G., Keeffe E. B., Lopez R. R., Sasaki A. W., Pinson C. W. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology. 1992 Oct;103(4):1307–1312. doi: 10.1016/0016-5085(92)91521-5. [DOI] [PubMed] [Google Scholar]
  3. Carman W. F., Trautwein C., van Deursen F. J., Colman K., Dornan E., McIntyre G., Waters J., Kliem V., Müller R., Thomas H. C. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology. 1996 Sep;24(3):489–493. doi: 10.1002/hep.510240304. [DOI] [PubMed] [Google Scholar]
  4. Chisari F. V., Filippi P., Buras J., McLachlan A., Popper H., Pinkert C. A., Palmiter R. D., Brinster R. L. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6909–6913. doi: 10.1073/pnas.84.19.6909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crippin J., Foster B., Carlen S., Borcich A., Bodenheimer H., Jr Retransplantation in hepatitis B--a multicenter experience. Transplantation. 1994 Mar 27;57(6):823–826. doi: 10.1097/00007890-199403270-00009. [DOI] [PubMed] [Google Scholar]
  6. Davies S. E., Portmann B. C., O'Grady J. G., Aldis P. M., Chaggar K., Alexander G. J., Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology. 1991 Jan;13(1):150–157. [PubMed] [Google Scholar]
  7. Demetris A. J., Todo S., Van Thiel D. H., Fung J. J., Iwaki Y., Sysyn G., Ming W., Trager J., Starzl T. E. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol. 1990 Sep;137(3):667–676. [PMC free article] [PubMed] [Google Scholar]
  8. Dienstag J. L., Perrillo R. P., Schiff E. R., Bartholomew M., Vicary C., Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 1995 Dec 21;333(25):1657–1661. doi: 10.1056/NEJM199512213332501. [DOI] [PubMed] [Google Scholar]
  9. Fang J. W., Tung F. Y., Davis G. L., Dolson D. J., Van Thiel D. H., Lau J. Y. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology. 1993 Sep;105(3):901–904. doi: 10.1016/0016-5085(93)90910-5. [DOI] [PubMed] [Google Scholar]
  10. Féray C., Samuel D., Gigou M., Paradis V., David M. F., Lemonnier C., Reynès M., Bismuth H. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology. 1995 Oct;22(4 Pt 1):1084–1089. [PubMed] [Google Scholar]
  11. Féray C., Zignego A. L., Samuel D., Bismuth A., Reynes M., Tiollais P., Bismuth H., Brechot C. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation. 1990 Jun;49(6):1155–1158. doi: 10.1097/00007890-199006000-00025. [DOI] [PubMed] [Google Scholar]
  12. Gish R. G., Keeffe E. B., Lim J., Brooks L. J., Esquivel C. O. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. J Hepatol. 1995 Mar;22(3):257–262. doi: 10.1016/0168-8278(95)80276-2. [DOI] [PubMed] [Google Scholar]
  13. Hoofnagle J. H., Di Bisceglie A. M., Waggoner J. G., Park Y. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology. 1993 Apr;104(4):1116–1121. doi: 10.1016/0016-5085(93)90281-g. [DOI] [PubMed] [Google Scholar]
  14. Kiyasu P. K., Ishitani M. B., McGory R. W., Gaffey M. J., Dickson R. C., Caldwell S. H., Stevenson W. S., Pruett T. L. Prevention of hepatitis B "rerecurrence" after a second liver transplant--the role of maintenance polyclonal HBIG therapy. Transplantation. 1994 Oct 27;58(8):954–956. doi: 10.1097/00007890-199410270-00018. [DOI] [PubMed] [Google Scholar]
  15. Kovarik J., Mayer G., Pohanka E., Schwarz M., Traindl O., Graf H., Smolen J. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation. 1988 Feb;45(2):402–405. doi: 10.1097/00007890-198802000-00031. [DOI] [PubMed] [Google Scholar]
  16. Krüger M., Tillmann H. L., Trautwein C., Bode U., Oldhafer K., Maschek H., Böker K. H., Broelsch C. E., Pichlmayr R., Manns M. P. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transpl Surg. 1996 Jul;2(4):253–262. doi: 10.1002/lt.500020402. [DOI] [PubMed] [Google Scholar]
  17. König V., Hopf U., Neuhaus P., Bauditz J., Schmidt C. A., Blumhardt G., Bechstein W. O., Neuhaus R., Lobeck H. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation. 1994 Sep 15;58(5):553–559. doi: 10.1097/00007890-199409150-00005. [DOI] [PubMed] [Google Scholar]
  18. Lam K. C., Lai C. L., Trepo C., Wu P. C. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med. 1981 Feb 12;304(7):380–386. doi: 10.1056/NEJM198102123040702. [DOI] [PubMed] [Google Scholar]
  19. Levy G. A., Sherker A., Fung L. S., Greig P. D., Sherman M., Blendis L. M. Relevance of hepatitis B viral DNA in assessment of potential liver allograft recipients. Transplant Proc. 1989 Apr;21(2):3333–3334. [PubMed] [Google Scholar]
  20. Ling R., Mutimer D., Ahmed M., Boxall E. H., Elias E., Dusheiko G. M., Harrison T. J. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology. 1996 Sep;24(3):711–713. doi: 10.1002/hep.510240339. [DOI] [PubMed] [Google Scholar]
  21. Lok A. S., Liang R. H., Chiu E. K., Wong K. L., Chan T. K., Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 1991 Jan;100(1):182–188. doi: 10.1016/0016-5085(91)90599-g. [DOI] [PubMed] [Google Scholar]
  22. Magnone M., Holley J. L., Shapiro R., Scantlebury V., McCauley J., Jordan M., Vivas C., Starzl T., Johnson J. P. Interferon-alpha-induced acute renal allograft rejection. Transplantation. 1995 Apr 15;59(7):1068–1070. doi: 10.1097/00007890-199504150-00030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Marcellin P., Samuel D., Areias J., Loriot M. A., Arulnaden J. L., Gigou M., David M. F., Bismuth A., Reynes M., Bréchot C. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology. 1994 Jan;19(1):6–12. [PubMed] [Google Scholar]
  24. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693–699. doi: 10.1056/NEJM199603143341104. [DOI] [PubMed] [Google Scholar]
  25. McGory R. W., Ishitani M. B., Oliveira W. M., Stevenson W. C., McCullough C. S., Dickson R. C., Caldwell S. H., Pruett T. L. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation. 1996 May 15;61(9):1358–1364. doi: 10.1097/00007890-199605150-00013. [DOI] [PubMed] [Google Scholar]
  26. McKenzie R., Fried M. W., Sallie R., Conjeevaram H., Di Bisceglie A. M., Park Y., Savarese B., Kleiner D., Tsokos M., Luciano C. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med. 1995 Oct 26;333(17):1099–1105. doi: 10.1056/NEJM199510263331702. [DOI] [PubMed] [Google Scholar]
  27. Mora N. P., Klintmalm G. B., Poplawski S. S., Cofer J. B., Husberg B. S., Gonwa T. A., Goldstein R. M. Recurrence of hepatitis B after liver transplantation: does hepatitis-B-immunoglobulin modify the recurrent disease? Transplant Proc. 1990 Aug;22(4):1549–1550. [PubMed] [Google Scholar]
  28. Muller R., Samuel D., Fassati L. R., Benhamou J. P., Bismuth H., Alexander G. J. 'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis. J Hepatol. 1994 Dec;21(6):1140–1143. doi: 10.1016/s0168-8278(05)80632-4. [DOI] [PubMed] [Google Scholar]
  29. Müller R., Gubernatis G., Farle M., Niehoff G., Klein H., Wittekind C., Tusch G., Lautz H. U., Böker K., Stangel W. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol. 1991 Jul;13(1):90–96. doi: 10.1016/0168-8278(91)90869-d. [DOI] [PubMed] [Google Scholar]
  30. Müller R., Gubernatis G., Farle M., Niehoff G., Klein H., Wittekind C., Tusch G., Lautz H. U., Böker K., Stangel W. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol. 1991 Jul;13(1):90–96. doi: 10.1016/0168-8278(91)90869-d. [DOI] [PubMed] [Google Scholar]
  31. Rimoldi P., Belli L. S., Rondinara G. F., Alberti A., DeCarlis L., Minola E., Pirotta V., Meroni A., Romani F., Sansalone V. Recurrent HBV/HDV infections under different immunoprophylaxis protocols. Transplant Proc. 1993 Aug;25(4):2675–2676. [PubMed] [Google Scholar]
  32. Samuel D., Bismuth A., Mathieu D., Arulnaden J. L., Reynes M., Benhamou J. P., Brechot C., Bismuth H. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet. 1991 Apr 6;337(8745):813–815. doi: 10.1016/0140-6736(91)92515-4. [DOI] [PubMed] [Google Scholar]
  33. Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou J. P., Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993 Dec 16;329(25):1842–1847. doi: 10.1056/NEJM199312163292503. [DOI] [PubMed] [Google Scholar]
  34. Shaw T., Amor P., Civitico G., Boyd M., Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother. 1994 Apr;38(4):719–723. doi: 10.1128/aac.38.4.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Terrault N. A., Holland C. C., Ferrell L., Hahn J. A., Lake J. R., Roberts J. P., Ascher N. L., Wright T. L. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg. 1996 Mar;2(2):132–138. doi: 10.1002/lt.500020209. [DOI] [PubMed] [Google Scholar]
  36. Terrault N. A., Zhou S., Combs C., Hahn J. A., Lake J. R., Roberts J. P., Ascher N. L., Wright T. L. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 1996 Dec;24(6):1327–1333. doi: 10.1002/hep.510240601. [DOI] [PubMed] [Google Scholar]
  37. Tipples G. A., Ma M. M., Fischer K. P., Bain V. G., Kneteman N. M., Tyrrell D. L. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology. 1996 Sep;24(3):714–717. doi: 10.1002/hep.510240340. [DOI] [PubMed] [Google Scholar]
  38. Todo S., Demetris A. J., Van Thiel D., Teperman L., Fung J. J., Starzl T. E. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 1991 Apr;13(4):619–626. [PMC free article] [PubMed] [Google Scholar]
  39. Tur-Kaspa R., Burk R. D., Shaul Y., Shafritz D. A. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1627–1631. doi: 10.1073/pnas.83.6.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wong D. K., Cheung A. M., O'Rourke K., Naylor C. D., Detsky A. S., Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med. 1993 Aug 15;119(4):312–323. doi: 10.7326/0003-4819-119-4-199308150-00011. [DOI] [PubMed] [Google Scholar]
  41. Wright H. I., Gavaler J. S., Van Theil D. H. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation. 1992 Jan;53(1):121–124. doi: 10.1097/00007890-199201000-00023. [DOI] [PubMed] [Google Scholar]
  42. Wright T. L., Combs C., Kim M., Ferrell L., Bacchetti P., Ascher N., Roberts J., Wilber J., Sheridan P., Urdea M. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology. 1994 Oct;20(4 Pt 1):773–779. doi: 10.1002/hep.1840200402. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES